From Financialexpress · Ashutosh Pati · · 1m 20s
Apollo Hospitals Hits Record, Max Health Jumps 4% on Macquarie Upgrades
Macquarie upgrades Apollo Hospitals and Max Healthcare to 'Outperform', sparking 34% upside for Max Health.
In brief
Macquarie upgrades Apollo Hospitals and Max Healthcare to 'Outperform', sparking 34% upside for Max Health. Macquarie raised target prices for Apollo Hospitals and Max Healthcare, predicting 15% and 34% upside from current prices. Originally reported by Financialexpress.
Macquarie upgrades both stocks
Global brokerage Macquarie double upgraded Apollo Hospitals Enterprise and Max Healthcare Institute shares to 'Outperform' from 'Underperform'.
Apollo Hospitals hits record high
Apollo Hospitals share price surged to a fresh record high of Rs 9,205, up over 5% from previous close.
Max Healthcare jumps 4%

Max Healthcare share price soared over 4% to a three-month high of Rs 1,090 apiece.
Macquarie's target price upgrades
Macquarie raised Apollo Hospitals target price to Rs 10,500 (15% upside) and Max Healthcare to Rs 1,450 (34% upside).
Why Macquarie prefers Max Healthcare
Macquarie sees Max Healthcare as better risk-reward with focused capital allocation and stronger EBITDA growth.
Max Healthcare's growth outlook
Macquarie expects Max Healthcare revenue to grow at 20% CAGR over FY26 to FY29 with 22% EBITDA growth.
What lies ahead for both companies
Both companies benefit as new capacity ramp ups proceed and sector valuations cool after earnings bottomed out.
What matters most
Macquarie raised target prices for Apollo Hospitals and Max Healthcare, predicting 15% and 34% upside from current prices.
Read the TL;DR — this story on one card.

